Tag: Magmaris

CRT 2019: Early resorption and low complications demonstrated for Magmaris

A press release reports that preliminary data from the BIOSOLVE-IV registry strengthen the clinical evidence in favour a bioresorbable magnesium scaffold (Magmaris, Biotronik) for...

Registry data for Biotronik’s bioresorbable scaffold Magmaris supports its roll-out into...

Preliminary data from the BIOSOLIVE-IV registry are consistent with the favourable safety outcomes seen with the magnesium bioresorbable scaffold (Magmaris, Biotronik) in previous studies...

EuroPCR 2018: Further evidence for safety and efficacy of Magmaris bioresorbable...

Data presented during EuroPCR (22 May – 25 May, Paris, France) provide further evidence on its continued safety and efficacy, also in a more complex...

TCT 2017: Pooled analysis of Magmaris studies continue to show no...

Data presented during the 2017 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October–2 November, Denver, USA), according to a press release, provide further evidence of...

EuroPCR 2017: Low risk of scaffold thrombosis with Magmaris

Data presented at EuroPCR (16–19 May, Paris, France) indicate that a metallic bioresorbable scaffold (Biotronik) is associated with a lower risk of scaffold thrombosis...

Magnesium 1,000 programme reveals high deployment success for Biotronik’s Magmaris scaffold

Biotronik has released details of the clinical performance of its Magmaris magnesium scaffold in 1,000 cases as part of the Magnesium 1,000 programme. Among...

TCT 2016: Physicians discuss their positive experiences of using a metallic...

At a symposium at the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October-2 November, Washington, DC, USA), physicians discussed their first experiences with a...